Cargando…
KMT2C-deficient tumors have elevated APOBEC mutagenesis and genomic instability in multiple cancers
The histone methyltransferase KMT2C is among the most frequently mutated epigenetic modifier genes in cancer and plays an essential role in MRE11-dependent DNA replication fork restart. However, the effects of KMT2C deficiency on genomic instability during tumorigenesis are unclear. Analyzing 9,663...
Autores principales: | Hu, Xiaoju, Biswas, Antara, De, Subhajyoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310081/ https://www.ncbi.nlm.nih.gov/pubmed/35898555 http://dx.doi.org/10.1093/narcan/zcac023 |
Ejemplares similares
-
Mutational signatures associated with exposure to carcinogenic microplastic compounds bisphenol A and styrene oxide
por: Hu, Xiaoju, et al.
Publicado: (2021) -
Analysis of gene expression and mutation data points on contribution of transcription to the mutagenesis by APOBEC enzymes
por: Chervova, Almira, et al.
Publicado: (2021) -
KMT2A histone methyltransferase contributes to colorectal cancer development by promoting cathepsin Z transcriptional activation
por: Fang, Yang, et al.
Publicado: (2019) -
Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation
por: Cai, Wesley L, et al.
Publicado: (2022) -
EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
por: Wakae, Kousho, et al.
Publicado: (2020)